Radioiodine (RAI) refractory differentiated thyroid cancer is an uncommon and challenging
situation that requires a multidisciplinary approach to therapeutic strategies. The definition of …

Background: To investigate the diagnostic performance of cytology (fine-needle aspiration
cytology [FNAC]), thyroglobulin (fine-needle aspiration thyroglobulin [FNA-Tg]), and …

Background: Radioactive iodine (RAI) is widely used in the management of differentiated
thyroid cancer (DTC). The impact of the time interval between total thyroidectomy (TT) and …

Objective: Although the prognostic role of BRAFV600E mutation in papillary thyroid
carcinoma (PTC) is controversial, the American Thyroid Association (ATA) includes the …

Increasingly sensitive diagnostic methods, better understanding of molecular
pathophysiology, and well-conducted prospective studies have changed the current …

Background: Risk stratification for persistent disease is an important step in pediatric
differentiated thyroid cancer (DTC) management. The dynamic risk stratification (DRS) is a …

Background: Thyroglobulin measurements in the washout of fine needle aspiration (FNA-Tg)
are an excellent tool to detect lymph node (LN) metastases of differentiated thyroid …

Background Lymph node metastasis is the major cause of increased recurrence and death
in patients with papillary thyroid carcinoma (PTC). We evaluate the clinicopathologic factors …

Differentiated thyroid carcinoma (DTC) is the most common malignant neoplasm of the
endocrine system. In children and adolescents, DTC usually presents as a more aggressive …

Background: The risk of recurrence in patients with differentiated thyroid cancer (DTC) can
be estimated based on their response to initial therapy. The aim of this study was to evaluate …